OCTN3: A Na+-independent L-carnitine transporter in enterocytes basolateral membrane

Journal of Cellular Physiology

Volumn 202, Issue 3, 2005, Pages 929-935

  Duran J M ^a   Peral, M J ^a   Calonge, M L ^a   Ilundain A A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCARNITINE; BETAINE; CARNITINE; GAMMA BUTYROBETAINE; MEMBRANE PROTEIN; PALMITOYLCARNITINE; PROTEIN OCTN3; TETRYLAMMONIUM; UNCLASSIFIED DRUG; VERAPAMIL;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; BASOLATERAL MEMBRANE; CELL PH; CHICKEN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTESTINE CELL; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SODIUM TRANSPORT;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; CARNITINE; CELL MEMBRANE; CELL POLARITY; CHICKENS; ENTEROCYTES; INTESTINE, SMALL; MEMBRANE PROTEINS; MICE; ORGANIC CATION TRANSPORT PROTEINS; RADIOLIGAND ASSAY; RATS; SODIUM; TRANSPORT VESICLES;

GALLUS GALLUS; MAMMALIA;

EID: 12944271972     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20193     Document Type: Article

References (42)

1. Bradford MM. 1976. A rapid and sensitive method for the quantification microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-254.
2. Calonge ML, Ilundáin A, Bolufer J, 1989. Ionic dependence of glycyl-sarcosine uptake by isolated chicken enterocytes. J Cell Physiol 138:579-585.
3. Dhalla NS, Kolar F, Shah KE, Ferrari R. 1991. Effects of some L-carnitine derivatives on heart membrane ATPases. Cardiovasc Drugs Ther 5:25-30.
4. Durán JM, Peral MJ, Calonge ML, Ilundáin AA. 2002. Functional characterization of intestinal L-carnitine transport. J Membr Biol 185:65-74.
5. Dyer J, Beechey RB, Gorvel JP, Smith RT, Wootton R, Shirazi-Beechey SP. 1990. Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles. Biochem J 269:565-571.
6. Enomoto A, Wempe MF, Tsuchida H, Shin HJ, Cha SH, Anzai N, Goto A, Sakamoto A, Niwa T, Kanai Y, Anders MW, Endou H. 2002. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem 277:36262-36271.
7. Flores CA, Hu C, Edmond J, Koldovsky O. 1996. Milk carnitine affects organ carnitine concentration in newborn rats. J Nutr 126:1673-1682.
8. Friedrich A, Prasad PD, Freyer D, Ganapathy V, Brust P. 2003. Molecular cloning and functional characterization of the OCTN2 transporter at the RBE4cells, an in vitro model of the blood-brain barrier. Brain Res 968:69-79.
9. Gross CJ, Henderson LM. 1984. Absorption of D- and L-carnitine by the intestine and kidney tubule in the rat. Biochim Biophys Acta 772:199-219.
10. Gross CJ, Henderson LM, Savaiano DA. 1986. Uptake of L-carnitine, D-carnitine, and acetyl-L-carnitine by isolated guinea-pig enterocytes. Biochim Biophys Acta 886:425-433.
11. Kerner J, Hoppel C. 1998. Genetic disorders of carnitine metabolism and their nutritional management. Annu Rev Nutr 18:179-206.
12. Lahjouji K, Malo C, Mitchell GA, Qureshi IA. 2002. L-carnitine transport in mouse renal and intestinal brush-border and basolateral membrane vesicles. Biochim Biophys Acta 1558:82-93.
13. Lamhonwah A-M, Skaug J, Scherer SW, Tein I. 2003. A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5). Biochem Biophys Res Commun 301:98-101.
14. Lerner A, Gruener N, Iancu TC. 1993. Serum carnitine concentrations in coeliac disease. Gut 34:933-935.
15. Liu QY, Rosenberg RL. 1996. Activation and inhibition of reconstituted cardiac L-type calcium channels by palmitoyl-L-carnitine. Biochem Biophys Res Commun 228:252-258.
16. Malow BA, Bake AC, Gleason PM, Blass JP. 1987. Carnitine in Alzheimer's disease fibroblast and patients. Clin Res 35:579A.
17. Mayatepek E, Nezu J, Tamai I, Oku A, Katsura M, Shimane M, Tsuji A. 2000. Two novel missense mutations of the OCTN2 gene (W283R and V446F) in a patient with primary systemic carnitine deficiency. Hum Mutat 15:118.
18. Meszaros J, Pappano AJ. 1990. Electrophysiological effects of L-palmitoylcarnitine in single ventricular myocytes. Am J Physiol 258:H931-H938.
19. 0,+ from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol 532:297-304.
20. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A. 1999. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
21. Nigam S, Muller S, Walzog B. 1992. Effect of staurosporine on fMet-Leu-Phe-stimulated human neutrophils: Dissociated release of inositol 1,4,5-trisphosphate, diacylglycerol and intracellular calcium. Biochim Biophys Acta 1135:301-308.
22. --dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance. J Pharmacol Exp Ther 291:778-784.
23. + exchange activity in brush border membrane vesicles isolated from chick small intestine. Eur J Biochem 231:682-686.
24. Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN, McClure RJ. 1995. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging 16:1-4.
25. Rebouche CJ, Mack DL. 1984. Sodium gradient-stimulated transport of L-carnitine into renal brush border membrane vesicles: Kinetics, specificity, and regulation by dietary carnitine. Arch Biochem Biophys 235:393-402.
26. Sekine T, Kusuhara H, Utsunomiya-Tate, Tsuda M, Sugiyama Y, Kanai Y, Endou H. 1998. Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine. Biochem Biophys Res Commun 251:586-591.
27. Shaw RD, Li BUK, Hamilton JW, Shug AL, Olsen WA. 1983. Carnitine transport in rat small intestine. Am J Physiol 245:G376-G381.
28. Shen JB, Pappano AJ. 1995. Palmitoyl-L-carnitine acts like ouabain on voltage, current, and contraction in guinea pig ventricular cells. Am J Physiol 268:H1027-H1036.
29. Shennan DB, Grant A, Ramsay RR, Burns C, Zammit VA. 1998. Characteristics of L-carnitine transport by lactating rat mammary tissue. Biochim Biophys Acta 1393:49-56.
30. Spagnoli A, Lucca U, Menasce G, Bandera L, Cizza G, Forloni G, Tettamanti M, Frattura L, Tiraboschi P, Cornelli M, et al. 1991. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 41:1726-1732.
31. Stapleton SR, Currie KP, Scott RH, Bell BA. 1992. Palmitoyl-DL-carnitine has calcium-dependent effects on cultured neurones from rat dorsal root ganglia. Br J Pharmacol 107:1192-1197.
32. Stieger B, O'Neill B, Krähenbühl S. 1995. Characterization of L-carnitine transport by rat kidney brush-border-membrane vesicles. Biochem J 309:643-647.
33. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A. 1997. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107-111.
34. Tamai I, Ohashi R, Nezu J-I, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. 1998. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 273:20378-20382.
35. Tamai I, Ohashi R, Nezu J, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A. 2000. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064-40072.
36. Tang NL, Ganapathy V, Wu X, Hui J, Seth P, Yuen PM, Wanders EJ, Fok TF, Hjelm NM. 1999. Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency. Hum Mol Genet 8:655-660.
37. Tein I. 2003. Carnitine transport: Pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis 26:147-169.
38. Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM. 1988. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med 319:1331-1336.
39. Wang Y, Ye J, Ganapathy V, Longo N. 1999. Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency. Proc Natl Acad Sci USA 96:2356-2360.
40. iand initiates transient inward current in adult ventricular myocytes. Am J Physiol 268:H2405-H2417.
41. Wu X, Prasad PD, Leibach FH, Ganapathy V. 1998. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-595.
42. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V. 1999. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), and organic cation/carnitine transporter. J Pharmacol Exp Ther 290:1482-1492.